<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>IRIS Tipologia:</title>
    <link>https://hdl.handle.net/10807/209</link>
    <description />
    <pubDate>Wed, 24 Jun 2026 06:11:31 GMT</pubDate>
    <dc:date>2026-06-24T06:11:31Z</dc:date>
    <item>
      <title>INTRODUCTION</title>
      <link>https://hdl.handle.net/10807/340464</link>
      <description>Titolo: INTRODUCTION
Autori: Finnegan J.; Fumagalli A.</description>
      <pubDate>Tue, 01 Jan 2019 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://hdl.handle.net/10807/340464</guid>
      <dc:date>2019-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Implementation failure: thromboprophylaxis in ambulatory patients with cancer</title>
      <link>https://hdl.handle.net/10807/340391</link>
      <description>Titolo: Implementation failure: thromboprophylaxis in ambulatory patients with cancer
Autori: Butera E.; Wang T. -F.; Pola R.; Carrier M.
Abstract: Venous thromboembolism (VTE) is a frequent complication in patients with cancer, especially those receiving systemic therapy in the ambulatory setting. Despite being a largely preventable condition, it remains a leading cause of morbidity and mortality in this patient population. Risk prediction models, such as the Khorana score, have been developed to stratify patients according to their underlying risk of VTE and identify those most likely to benefit from thromboprophylaxis by improving its risk-benefit ratio. Recent evidence supports the efficacy and safety of both low molecular weight heparin and direct oral anticoagulants in reducing VTE incidence in ambulatory patients with cancer who are receiving systemic therapy and are at high risk of VTE. Nevertheless, despite guideline recommendations warranting a risk-based approach, studies persistently show low adoption of thromboprophylaxis in this patient population. Barriers to implementation are complex, including clinician-, patient- and system-related factors. However, promising implementation strategies, including electronic health record integrated risk calculators, structured education programs, and patient-centered care pathways, have shown potential in improving adherence to guidelines and better clinical outcomes. This review summarizes the current evidence for thromboprophylaxis in patients with cancer, explores the challenges in translating evidence into practice, and highlights successful models designed to close the gap between guidelines and clinical practice.</description>
      <pubDate>Wed, 01 Jan 2025 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://hdl.handle.net/10807/340391</guid>
      <dc:date>2025-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Anticoagulant therapy today: from DOACS to factor XI inhibitors</title>
      <link>https://hdl.handle.net/10807/340387</link>
      <description>Titolo: Anticoagulant therapy today: from DOACS to factor XI inhibitors
Autori: Tondi P.; Pola R.
Abstract: N/A</description>
      <pubDate>Mon, 01 Jan 2024 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://hdl.handle.net/10807/340387</guid>
      <dc:date>2024-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>INTRODUCTION</title>
      <link>https://hdl.handle.net/10807/340003</link>
      <description>Titolo: INTRODUCTION
Autori: Mariagrazia Fanchi; Paola Dalla Torre del Tempio di Sanguinetto; Elena Mosconi
Abstract: The new historiographical paradigms (Biltereyst, Malby, Meers 2019), the relevant boost of film audience studies provided by networks such as HoMER, and the convergence of an increasing number of disciplines around cinema history: geography (Hallam, Roberts 2014; Treveri Gennari, O’Rawe, Hipkins 2019; Celata, Simone 2023), ethnography (Treveri Gennari et al, 2020; Stokes, Jones, Pett 2022; Antichi, Fedele, Garofalo 2023; Wessels et al 2022; Kuhn 2023), phenomenology (Hanich 2017), have, in recent years, produced an important growth in historical knowledge about movie theatres, the public, and, more generally, cinema experiences.&#xD;
Data-driven approaches and open science models (Deb Verhoeven’s work has been pivotal in this regard) have in addition contributed to deeply transforming the work of scholars, even in traditional fields, such as early cinema (Slugan, Biltereyst 2022), introducing new perspectives, encouraging to intersect many and different sources (Egan-Smith-Terrill, 2021), and developing longitudinal and comparative studies (van Oort, Whitehead, 2023). &#xD;
The research on movie theatres and moviegoing in Italy has certainly benefited from this conjuncture. However, some aspects and periods have been investigated less (systematically) than others. For example, the long and non-linear phase of the decline of cinemas and cinema-going in Italy, from the 1960s to the 1980s and the subsequent revival, from the second half of the 1990s have been understudied; cinema-going in rural areas and Southern regions, despite being the subject of some pioneering research (Pinna et al, 1958), still largely needs to be investigated. Likewise, the history of entrepreneurs running cinemas in Italy – predominantly family-run enterprises – is a relatively unexplored field. The history of the professions that revolve around cinema (managers, projectionists, cashiers…), in turn need to be completely reconstructed. In the same way, the experience of moviegoers, their relationship with cinema and the role that the viewing experience has taken on in their lives continue to offer many opportunities for study and investigation, strengthened by new investigation techniques and methodologies. &#xD;
Considering this landscape, this special issue aims to analyze how cinema and movie theatres shaped the history of territories, businesses, and people in the past and present, with a particular but non-exclusive focus on the case of Italy.</description>
      <pubDate>Mon, 01 Jan 2024 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://hdl.handle.net/10807/340003</guid>
      <dc:date>2024-01-01T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

